Acquisition of Multiple Generic Brands from Sandoz - Strides Pharma Science Ltd

Code BSE: 532531 NSE:

Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz The agreement spans four key markets—Western Sahara (covering 10 countries), Ghana, Nigeria, and Kenya. The branded generics portfolio of Sandoz, as a part of this deal, includes multiple brands across anti‑infective, cardiovascular, and dermatology therapeutic segments. Several of these products individually deliver annual sales exceeding US$1 million, eflecting their established brand equity and market demand.